A Clinical Study Evaluating Licaminlimab for Dry Eye Disease
Recruiting now · Phase 2/Phase 3
Conditions studied: Dry Eye Disease (DED)
In brief
The primary objective of this study is to evaluate the efficacy and safety of the topical ophthalmic administration of licaminlimab as compared to vehicle in participants with Dry Eye Disease and a specific genotype.
Key facts
- Study ID
- NCT07548632
- Run by
- Oculis
- People needed
- 160
- Starts
- 2026-04-16
- Expected to finish
- 2026-12-01
- Last updated by the study team
- 2026-07-06
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- East West Eye Institute — Aliso Viejo, California, United States (enrolling)
- Orange County Ophthalmology — Garden Grove, California, United States (enrolling)
- Global Research Management — Glendale, California, United States (enrolling)
- LoBue Laser and Eye Medical Center — Murrieta, California, United States (enrolling)
- Eye Research Foundation — Newport Beach, California, United States (enrolling)
- North Bay Eye Associates, Inc. — Petaluma, California, United States (enrolling)
- Vision Institute — Colorado Springs, Colorado, United States (enrolling)
- Segal Drug Trials, Inc. — Delray Beach, Florida, United States (enrolling)
- Oculus Research, Inc. — Garner, North Carolina, United States (enrolling)
- CORE, Inc — Shelby, North Carolina, United States (enrolling)
- Scott & Christie and Associates — Cranberry Township, Pennsylvania, United States (enrolling)
- Erie Retina Research — Erie, Pennsylvania, United States (enrolling)
- Total Eye Care, PA — Memphis, Tennessee, United States (enrolling)
- Piedmont Eye Center, Inc. — Lynchburg, Virginia, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.